Table 5: Histopathological spectrum of upper GI endoscopic biopsies.
Site |
Histopathological Diagnosis |
Paediatric group |
Adult group |
Geriatric group |
Esophagus |
Squamous cell carcinoma (Figure 1) |
1 (1.5%) |
84 (21%) |
24 (28%) |
Non-specific inflammation |
2 (3%) |
9 (2%) |
3 (3%) |
|
GERD |
1 (1.5%) |
7 (2%) |
3 (3%) |
|
Adeno-squamous carcinoma |
0 |
3 (1%) |
2 (2%) |
|
TOTAL |
4 (6%) |
103 (26%) |
32 (36%) |
|
Stomach |
Adenocarcinoma (Figure 2a and Figure 2b) |
0 |
3 (1%) |
2 (2%) |
GIST (Figure 3) |
1 (1.5%) |
4 (1%) |
2 (2%) |
|
Non-specific inflammation (Figure 4a and Figure 4b) |
2 (1.5%) |
105 (26%) |
10 (11%) |
|
H. Pylori induced gastritis (Figure 5a and Figure 5b) |
1 (1.5%) |
57 (14%) |
5 (6%) |
|
Chronic atrophic gastritis (Figure 6) |
1 (1.5%) |
21 (5%) |
3 (3%) |
|
TOTAL |
5 (6%) |
190 (47%) |
22 (24%) |
|
Duodenum |
Villous atrophy |
1 (1.5%) |
7 (2%) |
2 (2%) |
Non-specific inflammation |
7 (11%) |
38 (9%) |
4 (5%) |
|
Duodenal ulcer |
5 (9%) |
22 (5%) |
2 (2%) |
|
Dysplasia |
2 (3%) |
4 (1%) |
2 (2%) |
|
Celiac disease |
14 (22%) |
3 (1%) |
1 (1%) |
|
Total |
29 (46.5%) |
74 (18%) |
11 (12%) |